Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 20/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL462322 | 1.00 | REN (0.50) | REN | |
| SCHEMBL623311 | 1.00 | REN (0.50) | REN | |
| SCHEMBL2440502 | 1.00 | REN (0.50) | REN | |
| SCHEMBL19304579 | 1.00 | REN (0.50) | REN | |
| SCHEMBL19304576 | 1.00 | REN (0.50) | REN | |
| SCHEMBL19304577 | 1.00 | REN (0.50) | REN | |
| SCHEMBL6045352 | 0.92 | REN (0.48) | REN | |
| SCHEMBL6044937 | 0.92 | REN (0.48) | REN | |
| SCHEMBL10119482 | 0.92 | REN (0.49) | REN | |
| SCHEMBL10144615 | 0.91 | REN (0.41) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3019466-B1 | PROCESS FOR PREPARING 8-ARYLOCTANOIC ACIDS | F I S - FABBRICA ITALIANA SINTETICI S P A (IT) | 2017-09-06 | — | — | EP | disclosed |
| WO-2009049837-A1 | PROCESS FOR PREPARING 8-HYDRAZINO-8-ARYLOCTANOYL DERIVATIVES AND THEIR USE | REUTER CHEMISCHER APPARATEBAU KG (DE) | 2009-04-23 | — | — | WO | disclosed |
| EP-2010480-A1 | METHOD FOR THE PRODUCTION OF 8-ARYL-OCTANOYL DERIVATIVES | Reuter Chemische Apparatebau KG (DE) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007118681-A1 | METHOD FOR THE PRODUCTION OF 8-ARYL-OCTANOYL DERIVATIVES | REUTER CHEMISCHER APPARATEBAU KG (DE) | 2007-10-25 | — | — | WO | disclosed |